University of the Witwatersrand, Johannesburg (Respiratory and Meningeal Pathogens Research unit)
Welcome,         Profile    Billing    Logout  
 11 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Madhi, Shabir A
MV/VV/Hep-AV, NCT03330171: Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine

Active, not recruiting
4
278
RoW
Measles vaccine, Measles vaccine (MeasBio) 0.5 mL, Hepatitis-A vaccine, Hepatitis-A vaccine (Varilrix) 0.5 mL, Varicella vaccine, Varicella vaccine (Avaxim Paediatric) 0.5 mL
University of Witwatersrand, South Africa
Measles, Varicella, Hepatitis A
02/19
12/22
NCT04444674: COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection

Active, not recruiting
1/2
2130
RoW
ChAdOx1 nCoV-19, Normal saline 0.9%
University of Oxford, Medical Research Council, South Africa, Bill and Melinda Gates Foundation, Wits Health Consortium (Pty) Ltd, University of Witwatersrand, South Africa
Coronavirus
12/20
12/21
PCV1+1_FU, NCT04275284: Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children

Completed
N/A
600
RoW
PCV10, Synflorix, PCV13, Prevnar13
University of Witwatersrand, South Africa
Pneumonia, Meningitis
12/22
12/22

Download Options